Portland Investment Counsel Inc.
Source: SEC Form 13F · as of Mar 2026Portland Investment Counsel Inc. holds 8 biotech & pharma companies tracked by BioSniper, totaling $5.6M in value as of Mar 2026 (SEC Form 13F).
Companies held
8
Total value held
$5.6M
BioSniper AIPage context preserved
Prepared research question
What matters most for Telix Pharmaceuticals Limited (TLX)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| TLXTelix Pharmaceuticals Limited | 266,200 | $2.5M |
| ONCBeOne Medicines Ltd. | 3,000 | $891K |
| OLMAOlema Pharmaceuticals, Inc. | 50,000 | $746K |
| REGNREGENERON PHARMACEUTICALS, INC. | 654 | $505K |
| IOVAIOVANCE BIOTHERAPEUTICS, INC. | 130,000 | $456K |
| NUVLNuvalent, Inc. | 2,000 | $205K |
| ARVNARVINAS, INC. | 14,000 | $148K |
| BCYCBICYCLE THERAPEUTICS PLC | 15,000 | $70K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.